FK
Farman Khan
About Farman Khan
Data last updated:
Farman Khan is a Director at Neorangic Healthcare Private Limited (since 2024) and Director at Roseveda Wellness Private Limited (since 2024). The companies operate in Chemicals and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹1.35 Cr; the largest is Neorangic Healthcare Private Limited at ₹1.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Mar 2024 | 2021 | ₹1.34 Cr (FY 2025) | Active | |
| Director | 04 Jul 2024 | 2024 | ₹1.2 Lakh (FY 2025) | Active |
Board colleagues of Farman Khan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aysha | 10192565 | Neorangic Healthcare Private Limited | Director |
| Mohammad Anas | 10695615 | Roseveda Wellness Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Farman Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Farman Khan
Farman Khan currently holds 2 directorships: Neorangic Healthcare Private Limited (Director, since 16 Mar 2024, revenue ₹1.34 Cr (FY 2025)); Roseveda Wellness Private Limited (Director, since 04 Jul 2024, revenue ₹1.2 Lakh (FY 2025)).
Farman Khan was first appointed on 16 Mar 2024 as Director at Neorangic Healthcare Private Limited.
The 2 current companies of Farman Khan that report revenue have a combined latest revenue of ₹1.35 Cr: Neorangic Healthcare Private Limited ₹1.34 Cr (FY 2025); Roseveda Wellness Private Limited ₹1.2 Lakh (FY 2025).
The current boards of Farman Khan's companies include Aysha (Neorangic Healthcare Private Limited), Mohammad Anas (Roseveda Wellness Private Limited).